Biology of Blood and Marrow Transplantation
Volume 13, Issue 6 , Pages 675-682 , June 2007

Major ABO Blood Group Mismatch Increases the Risk for Graft Failure after Unrelated Donor Hematopoietic Stem Cell Transplantation

  • Mats Remberger

      Affiliations

    • Department of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    • Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    • Corresponding Author InformationCorrespondence and reprint requests: Mats Remberger, PhD, Clinical Immunology, Karolinska University Hospital, SE-141 86 Stockholm, Sweden.
    • ,
  • Emma Watz

      Affiliations

    • Department of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    • ,
  • Olle Ringdén

      Affiliations

    • Department of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    • Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    • ,
  • Jonas Mattsson

      Affiliations

    • Department of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    • Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    • ,
  • Agneta Shanwell

      Affiliations

    • Department of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    • ,
  • Agneta Wikman

      Affiliations

    • Department of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

Received 5 October 2006 ,Accepted 30 January 2007.

References 

  1. Storb R, Doney KC, Thomas ED, et al. Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood. 1982;59:236–246
  2. Ringdén O, Remberger M, Svahn BM, et al. Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single-center. Transplantation. 2006;81:718–725
  3. Champlin R, Gale RP. Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies. Semin Hematol. 1987;24:55–67
  4. Goldman JM, Schmitz N, Niethammer D, Gratwohl A. Allogeneic and autologous transplantation for hematological diseases, solid tumours and immune disorders: current practice in Europe in 1998 (Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation). Bone Marrow Transplant. 1998;21:1–7
  5. Ringdén O, Deeg HJ. Clinical spectrum of graft-versus-host disease. In:  Ferrara JL,  Deeg HJ,  Burakoff S editor. Graft vs Host Disease. 2nd ed.. New York: Marcel Dekker, Inc; 1996;p. 525–559
  6. Meyers J, Thomas E. Infection complicating bone marrow transplantation. In:  Rubin RH,  Young LS editor. Clinical Approach to Infection in the Compromised Host. New York: Plenum Publishing Corp; 1988;p. 525–556
  7. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. [see comments] N Engl J Med. 1993;328:593–602
  8. Petersdorf EW, Longton GM, Anasetti C, et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood. 1997;89:1818–1823
  9. McSweeney PA, Niederwieser D, Shizuru JA, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus- tumor effects. Blood. 2001;97:3390–3400
  10. Davies SM, Weisdorf DJ, Haake RJ, et al. Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1994;14:73–77
  11. Davies SM, Ramsay NK, Haake RJ, et al. Comparison of engraftment in recipients of matched sibling of unrelated donor marrow allografts. Bone Marrow Transplant. 1994;13:51–57
  12. Remberger M, Svahn B-M, Hentschke P, Löfgren C, Ringdén O. Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation. Bone Marrow Transplant. 1999;24:823–830
  13. Bacigalupo A, Lamparelli T, Bruzzi P, et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood. 2001;98:2942–2947
  14. Buckner CD, Clift RA, Sanders JE, et al. ABO-incompatible marrow transplants. Transplantation. 1978;26:233–238
  15. Stussi G, Seebach L, Muntwyler J, et al. Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation: a single-centre experience. Br J Haematol. 2001;113:251–253
  16. Stussi G, Muntwyler J, Passweg JR, et al. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone Marow Transplant. 2002;30:87–93
  17. Mehta J, Powles R, Sirohi B, et al. Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?. Bone Marrow Transplant. 2002;30:853–859
  18. Olerup O, Zetterqvist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours (An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation). Tissue Antigens. 1992;39:225–235
  19. Schaffer M, Aldener-Cannavé A, Remberger M, et al. Roles of HLA-A, HLA-B and HLA-DPA1 incompatibility in the outcome in unrelated stem cell transplantation. Tissue Antigens. 2003;62:243–250
  20. Ringdén O, Remberger M, Runde V, et al. Peripheral blood stem cell (PBSC) transplantation from unrelated donors: a comparison with bone marrow transplantation. Blood. 1999;94:455–464
  21. Remberger M, Svahn BM, Mattsson J, Ringden O. Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation. Transplantation. 2004;78:122–127
  22. Storb R, Deeg H, Whitehead J, Appelbaum F, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. N Engl J Med. 1986;314:729–735
  23. Hägglund H, Ringdén O, Öhman S, Remberger M, Carlens S, Mattsson J. A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation. Bone Marrow Transplant. 1998;24:831–836
  24. Remberger M, Naseh N, Aschan J, et al. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD grades II-IV. Bone Marrow Transplant. 2003;32:217–223
  25. Mattsson J, Uzunel M, Tammik L, Aschan J, Ringdén O. Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation. Leukemia. 2001;15:1976–1985
  26. Aversa F, Tabilio A, Terenzi A, et al. Successful engraftment of T-cell-depleted haploidentical “three-loci” incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood. 1994;84:3948–3955
  27. Rozman P, Kosir A, Bohinjec M. Is the ABO incompatibility a risk factor in bone marrow transplantation?. Transpl Immunol. 2005;14:159–169
  28. Seebach JD, Stussi G, Passweg JR, et al. ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biol Blood Marrow Transplant. 2005;11:1006–1013
  29. Badros A, Tricot G, Toor A, et al. ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning. Transfusion. 2002;42:205–209
  30. Tazzari PL, Rondelli D, Re F, et al. Antibodies reactive with neutrophils following allogeneic haematopoietic stem cell transplantation. Eur J Haematol. 1999;62:57–62

PII: S1083-8791(07)00145-0

doi: 10.1016/j.bbmt.2007.01.084

Biology of Blood and Marrow Transplantation
Volume 13, Issue 6 , Pages 675-682 , June 2007

Article Tools

* Image Usage & Resolution